- /
- Supported exchanges
- / US
- / PBM.NASDAQ
Psyence Biomedical Ltd. Common Shares (PBM NASDAQ) stock market data APIs
Psyence Biomedical Ltd. Common Shares Financial Data Overview
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Psyence Biomedical Ltd. Common Shares (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at €19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only €19.99
Get Psyence Biomedical Ltd. Common Shares data using free add-ons & libraries
Get Psyence Biomedical Ltd. Common Shares Fundamental Data
Psyence Biomedical Ltd. Common Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -6 232 245
- Earnings Per Share: -12
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Psyence Biomedical Ltd. Common Shares Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2025-11-20
- EPS/Forecast: 0
Get Psyence Biomedical Ltd. Common Shares End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Psyence Biomedical Ltd. Common Shares News
New
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Staar Surgical (NASDAQ:STAA) shares rose 15.3% to $33.9 during Wednesday's after-market session. The company's market cap stands at $1.3 billion. As per the press release, Q1 earnings came ou...
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a clinical-stage biopharmaceutical company advancing nature-derived ps...
Psychedelic Shares Rise Following Trump's Executive Order to Accelerate Treatments for Serious Mental Illness
Compass Pathways (CMPS) and other psychedelic shares were up in Monday premarket activity, after US PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Trump Trade: President to sign order on psychedelic used for PTSD
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fl...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only €19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.